
Advanced chemotherapy, targeted and biological therapies for adult cancers — delivered safely in HEPA-filtered, monitored environments.
The Department of Medical Oncology at Sree Mookambika Cancer Centre provides comprehensive treatment for adult cancers through advanced chemotherapy, targeted therapy and biological therapies.
The department is supported by modern infrastructure and a team of experienced oncology specialists committed to safe, evidence-based and patient-centered care.

Leads the Medical Oncology programme with deep expertise in solid tumor chemotherapy, targeted therapy and haemato-oncology — guiding individualised, precision-led treatment for every patient.
HEPA-filtered, pressure-controlled treatment rooms and a Biological Safety Cabinet ensure asepsis, safe drug handling and patient safety.
Targeted therapy and monoclonal antibodies for adult solid tumors.
Treatment based on evidence-based, international guidelines.
Dedicated bays, monitoring and trained oncology nurses.
Inpatient care in general wards and private rooms.
Safe chemotherapy drug preparation under laminar airflow.
Pressure-controlled treatment rooms with strict asepsis control.
Critical care for chemotherapy-related complications.
Comprehensive medical oncology services across solid tumors and blood cancers.
Diagnostic and therapeutic interventions performed by the department.
Treatment plans are individualised based on tumor type, stage, molecular characteristics and patient health — leveraging precision oncology strategies.
Safe and efficient chemotherapy administration in a comfortable, patient-friendly environment — patients return home the same day.
A dedicated BMT facility is being established with HEPA-filtered isolation rooms, advanced laboratory support and a multidisciplinary transplant team.
Significantly enhances access to advanced cancer care in South Tamil Nadu and neighbouring regions.
Comprehensive histopathological evaluation and intraoperative frozen section analysis allow real-time margin assessment — supporting precise diagnosis, staging and surgical decision-making across the multidisciplinary cancer team.
| S.No | Name | Designation | Date of Joining |
|---|---|---|---|
| 1 | Dr. Sreejith. G. Nair | Professor & HOD | 10-02-2025 |
| 2 | Dr. Rakul Nambiar. K | Assistant Professor | 01-05-2020 |